Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor Symptoms

Completed · Phase 2

Conditions studied: Vasomotor Symptoms (VMS)

In brief

An open-label, long term extension study of MT-8554 in postmenopausal women experiencing moderate to severe vasomotor symptoms who completed Study MT-8554-A01

Key facts

Study ID
NCT03541200
Run by
Tanabe Pharma America, Inc.
People needed
190
Starts
2018-04-18
Expected to finish
2019-11-15
Last updated by the study team
2026-01-23

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.